Babitha Kosuri’s Post

When unexpected #RTSM challenges occur, you need more than technology to keep your #ClinicalTrial running. Learn how the experts behind Calyx #IRT tackled a mid-study packaging change to keep a sponsor's critical trial on track. https://lnkd.in/gxtbdyDa #Randomization #TrialSupplyManagement #ChooseCalyx Catherine Green, DBA, PMP

We’re proud to have supported Iovance on this milestone approval and excited about its impact on #Melanoma patients and the #Oncology research community. Read the announcement. https://lnkd.in/gwreSw96 #MedicalImaging #ClinicalTrials #Oncology #ChooseCalyx

There's a reason why so many worldwide sponsors repeatedly turn to Calyx for their important #Oncology trial imaging. Experience matters. Learn more. https://lnkd.in/gwBFtGpR #MedicalImaging #ClinicalTrials #ChooseCalyx

Meet with #Calyx #MedicalImaging scientists during #ASCO2024 and learn how their extensive #Oncology #ClinicalTrial imaging experience can help your development program succeed. Schedule a meeting. https://lnkd.in/eHHGr_SB #ChooseCalyx Dr. Oliver Bohnsack Surabhi Bajpai Rudresh Jarecha Elif Sikoglu

ICYMI...We’re proud to have supported Iovance on this milestone approval – the first tumor-infiltrating lymphocyte (#TIL\) therapy for #SolidTumors – and excited about its impact on #Melanoma patients and the #Oncology research community. Learn more. https://lnkd.in/g7DuG7Rk #MedicalImaging #ClinicalTrials #Oncology #ChooseCalyx

Going to #ASCO2024? Learn how Calyx’s #MedicalImaging scientists combine broad #Oncology imaging experience with current best practices to implement a future-focused imaging strategy that meets your #ClinicalDevelopment objectives. Visit Booth 10098. https://lnkd.in/g8MMpw8Z #ClinicalTrials #ChooseCalyx

We’re proud to have supported Iovance on this milestone approval – the first tumor-infiltrating lymphocyte (#TIL\) therapy for #SolidTumors – and excited about its impact on #Melanoma patients and the #Oncology research community. https://lnkd.in/gmQ72Hy5 #MedicalImaging #ClinicalTrials #Oncology #ChooseCalyx

Attending #RSIDM24? Don't miss today's session chaired by Calyx’s Jo English to gain insights into the current status of ePI adoption and the essential factors needed for its global implementation. https://lnkd.in/gMVcApwN #RIM #ChooseCalyx #Regulatory

In #ClinicalTrials investigating Antibody Drug Conjugates (#ADC\), worldwide regulators are asking sponsors to monitor for ILD toxicity. Understand the implications and how to meet #regulatory expectations in this quick read by Calyx's Rohit Sood MD., PhD., CFP https://lnkd.in/g3kSXCUU #MedicalImaging #Oncology #ChooseCalyx

Is your RIM system future-ready? Visit us at Booth 112 at #RSIDM2024 next week and learn why you can rely on Calyx RIM to keep you up to date. https://lnkd.in/g4V7F-wR #Regulatory #RIM #ChooseCalyx